Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
IM or SC 12/week as directed
benefit: FDA only looked at risk, ignored benefits Off-label use: Doctors prescribe drugs off-label all the time Patient access: People are suffering and need options Regulatory capture: Big Pharma doesn't want cheap peptides competing The problem with these arguments: It's NOT off-label use Off-label only applies to FDA-approved drugs
This product page is designed to help researchers compare available vial sizes, vendor pricing, discount-code availability, third-party verification signals, supplier links, delivery notes, and research-use-only context before leaving PeptideStack for an external vendor
Despite pointing out the BNF and NICE guideline recommendation that more frequent injections are necessary if symptoms persist and that patients with neurological symptoms should be on a maintenance dose of every 8 weeks, this doctors practice told her that it is their surgerys policy to only give 12 weekly and under no circumstances would she get any more frequent injections despite a formal diagnosis of PA
